Literature DB >> 9595619

Development of a clinical prediction model for an ordinal outcome: the World Health Organization Multicentre Study of Clinical Signs and Etiological agents of Pneumonia, Sepsis and Meningitis in Young Infants. WHO/ARI Young Infant Multicentre Study Group.

F E Harrell1, P A Margolis, S Gove, K E Mason, E K Mulholland, D Lehmann, L Muhe, S Gatchalian, H F Eichenwald.   

Abstract

This paper describes the methodologies used to develop a prediction model to assist health workers in developing countries in facing one of the most difficult health problems in all parts of the world: the presentation of an acutely ill young infant. Statistical approaches for developing the clinical prediction model faced at least two major difficulties. First, the number of predictor variables, especially clinical signs and symptoms, is very large, necessitating the use of data reduction techniques that are blinded to the outcome. Second, there is no uniquely accepted continuous outcome measure or final binary diagnostic criterion. For example, the diagnosis of neonatal sepsis is ill-defined. Clinical decision makers must identify infants likely to have positive cultures as well as to grade the severity of illness. In the WHO/ARI Young Infant Multicentre Study we have found an ordinal outcome scale made up of a mixture of laboratory and diagnostic markers to have several clinical advantages as well as to increase the power of tests for risk factors. Such a mixed ordinal scale does present statistical challenges because it may violate constant slope assumptions of ordinal regression models. In this paper we develop and validate an ordinal predictive model after choosing a data reduction technique. We show how ordinality of the outcome is checked against each predictor. We describe new but simple techniques for graphically examining residuals from ordinal logistic models to detect problems with variable transformations as well as to detect non-proportional odds and other lack of fit. We examine an alternative type of ordinal logistic model, the continuation ratio model, to determine if it provides a better fit. We find that it does not but that this model is easily modified to allow the regression coefficients to vary with cut-offs of the response variable. Complex terms in this extended model are penalized to allow only as much complexity as the data will support. We approximate the extended continuation ratio model with a model with fewer terms to allow us to draw a nomogram for obtaining various predictions. The model is validated for calibration and discrimination using the bootstrap. We apply much of the modelling strategy described in Harrell, Lee and Mark (Statist. Med. 15, 361-387 (1998)) for survival analysis, adapting it to ordinal logistic regression and further emphasizing penalized maximum likelihood estimation and data reduction.

Entities:  

Mesh:

Year:  1998        PMID: 9595619     DOI: 10.1002/(sici)1097-0258(19980430)17:8<909::aid-sim753>3.0.co;2-o

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  44 in total

1.  Comparison of 16S rRNA gene PCR and BACTEC 9240 for detection of neonatal bacteremia.

Authors:  J A Jordan; M B Durso
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

2.  Evaluating diagnostic accuracy of genetic profiles in affected offspring families.

Authors:  Jerome Carayol; Frédéric Tores; Inke R König; Jörg Hager; Andreas Ziegler
Journal:  Stat Med       Date:  2010-09-30       Impact factor: 2.373

3.  Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemia.

Authors:  Antonio R Lucena-Araujo; Juan L Coelho-Silva; Diego A Pereira-Martins; Douglas R Silveira; Luisa C Koury; Raul A M Melo; Rosane Bittencourt; Katia Pagnano; Ricardo Pasquini; Elenaide C Nunes; Evandro M Fagundes; Ana B Gloria; Fábio Kerbauy; Maria de Lourdes Chauffaille; Israel Bendit; Vanderson Rocha; Armand Keating; Martin S Tallman; Raul C Ribeiro; Richard Dillon; Arnold Ganser; Bob Löwenberg; P J M Valk; Francesco Lo-Coco; Miguel A Sanz; Nancy Berliner; Eduardo M Rego
Journal:  Blood       Date:  2019-07-10       Impact factor: 22.113

4.  A Clinical Prediction Algorithm to Stratify Pediatric Musculoskeletal Infection by Severity.

Authors:  Michael A Benvenuti; Thomas J An; Megan E Mignemi; Jeffrey E Martus; Gregory A Mencio; Stephen A Lovejoy; Jonathan G Schoenecker; Derek J Williams
Journal:  J Pediatr Orthop       Date:  2019-03       Impact factor: 2.324

5.  Development of a nomogram for individualizing hip fracture risk in men and women.

Authors:  N D Nguyen; S A Frost; J R Center; J A Eisman; T V Nguyen
Journal:  Osteoporos Int       Date:  2007-03-17       Impact factor: 4.507

6.  Pneumonia Risk Stratification Scores for Children in Low-Resource Settings: A Systematic Literature Review.

Authors:  Katrina V Deardorff; Eric D McCollum; Amy Sarah Ginsburg
Journal:  Pediatr Infect Dis J       Date:  2018-08       Impact factor: 2.129

7.  Prediction of two month modified Rankin Scale with an ordinal prediction model in patients with aneurysmal subarachnoid haemorrhage.

Authors:  Roelof Risselada; Hester F Lingsma; Andrew J Molyneux; Richard S C Kerr; Julia Yarnold; Mary Sneade; Ewout W Steyerberg; Miriam C J M Sturkenboom
Journal:  BMC Med Res Methodol       Date:  2010-09-29       Impact factor: 4.615

8.  A Preconception Nomogram to Predict Preterm Delivery.

Authors:  Shilpi S Mehta-Lee; Anton Palma; Peter S Bernstein; David Lounsbury; Nicolas F Schlecht
Journal:  Matern Child Health J       Date:  2017-01

9.  The healing potential of stable juvenile osteochondritis dissecans knee lesions.

Authors:  Eric J Wall; Jason Vourazeris; Gregory D Myer; Kathleen H Emery; Jon G Divine; Todd G Nick; Timothy E Hewett
Journal:  J Bone Joint Surg Am       Date:  2008-12       Impact factor: 5.284

10.  Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial.

Authors:  M J Davies; S Heller; T C Skinner; M J Campbell; M E Carey; S Cradock; H M Dallosso; H Daly; Y Doherty; S Eaton; C Fox; L Oliver; K Rantell; G Rayman; K Khunti
Journal:  BMJ       Date:  2008-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.